RecruitingNCT05865093
Early Visual Functions in Patients at Risk of Developing Cerebral Visual Impairment. A Pilot Study
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
700 participants
Start Date
Jul 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the study is to assess visual function from neonatal age to 36 months of age in infants at risk of visual impairment due to brain lesion or ocular pathology
Eligibility
Min Age: 2 DaysMax Age: 36 Months
Inclusion Criteria6
- Age between 34 weeks of post-menstrual age and 36 months of life in children born before 37 weeks gestational age
- Genetic syndroms
- Hypoxic Hischemic Encephalopathy
- Brain malformation
- Metabolic diseases
- Ocular pathologies
Exclusion Criteria2
- Patients at low risk of developing neurological outcomes
- Refusal of informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05865093
Related Trials
Touching the World With a Cane: Cognitive and Neural Processes
NCT051998961 location
Hemianopsia Rehabilitation After Stroke or Brain Injury
NCT062412091 location
Improving Visual Field Deficits With Noninvasive Brain Stimulation
NCT050852101 location
Visual Frailty in Ageing
NCT066041042 locations
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
NCT0584498222 locations